OFLIMET is a multi-action gastrointestinal anti-infective suspension designed for selected infectious conditions where antibacterial/antiprotozoal coverage is clinically appropriate, while also addressing associated gas-related discomfort. Its liquid format provides convenient administration where a suspension is preferred. A useful PCD Pharma Gastro & Anti-Infective portfolio product.
Selected gastrointestinal infections involving susceptible organisms.
No, it provides symptomatic gas relief.
Use only under prescription and complete the prescribed course. Avoid alcohol during Metronidazole therapy and for the recommended period afterwards.
Nausea, diarrhea, abdominal discomfort, metallic taste, dizziness and headache may occur.
OFLIMET: Ofloxacin inhibits bacterial DNA replication, Metronidazole acts against susceptible anaerobic bacteria and protozoa, while Simethicone provides symptomatic relief from gas and bloating.
